Secondary Malignant Neoplasm Of Pancreas — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for secondary malignant neoplasm of pancreas. 14 active patents protecting 1 drugs from 1+ originators. First major cliff: 2027. Daily refresh.

1
Approved drugs
14
Active US patents
55/100
Avg vulnerability
—
Annual revenue covered

Originators in Secondary Malignant Neoplasm Of Pancreas

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Pfizer 14 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating secondary malignant neoplasm of pancreas. Each bar = one year. Y-axis scaled to peak year (8 patents).

1
27
1
28
8
33
4
36

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Camptosar
Irinotecan Hydrochloride
 Pfizer 14 55 — 2027-01-06

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
12364691 Camptosar method of use 75 2033-06-12
11344552 Camptosar method of use 75 2036-08-19
11369597 Camptosar method of use 70 2033-06-12
9452162 Camptosar method of use 62 2033-06-12
10980795 Camptosar method of use 62 2033-06-12
9364473 Camptosar method of use 62 2033-06-12
9492442 Camptosar method of use 62 2033-06-12
9717724 Camptosar method of use 62 2033-06-12
9339497 Camptosar method of use 62 2033-06-12
12059497 Camptosar formulation 55 2036-10-15

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
8147867 Camptosar composition of matter 17 2028-08-29
8329213 Camptosar composition of matter 22 2027-01-06
10993914 Camptosar formulation 42 2036-10-15
10456360 Camptosar formulation 42 2036-10-15
12059497 Camptosar formulation 55 2036-10-15
9452162 Camptosar method of use 62 2033-06-12
10980795 Camptosar method of use 62 2033-06-12
9364473 Camptosar method of use 62 2033-06-12
9492442 Camptosar method of use 62 2033-06-12
9717724 Camptosar method of use 62 2033-06-12

Related